Given Imaging is redefining the field of gastrointestinal (GI) diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting GI disorders. Given Imaging pioneered PillCam capsule endoscopy and today offers a range of PillCam video capsules and related products.
The PillCam video capsule is a disposable, miniature video camera contained in a capsule that can be easily ingested by the patient. The capsule transmits high quality color images of the GI tract that enable physicians to visualize the small intestine and esophagus. PillCam SB, the only ingestible diagnostic tool that allows direct visualization of the entire small bowel, became available in 2001 and has demonstrated superior diagnostic efficacy. PillCam ESO was cleared for use in the U.S. in November 2004 and provides a patient-friendly alternative for esophageal imaging.
Management
Given Imaging is led by an international management team with extensive experience in endoscopy, medical technologies and imaging, global marketing and operations, regulatory affairs and finance. The Company’s corporate headquarters, research and development laboratories, and manufacturing facilities, are located in Yoqneam, Israel. North American headquarters are located in the USA in Duluth, GA. European headquarters are in Hamburg, Germany. Additional sales and marketing offices are located in Paris, Madrid, Sydney and Tokyo, and a second production facility is located in Ireland. Given Imaging’s technology is currently marketed in the United States and 60 other countries.
Shareholders
Given Imaging is publicly listed on The NASDAQ Stock Market (GIVN) and on the Tel Aviv Stock Exchange.